Select Page

GeneCopoeia Products & Services for Experimental Biology 2021

GeneCopoeia is an industry leader in the production of plasmid clones and viral particles for gene function studies, antigen protein microarrays for autoimmunity and other research, reagent kits, and stable cell lines. Our plasmid clones for ORF cDNA, gene promoters, shRNA, CRISPR, microRNAs, and others, are available for human, mouse, and rat in hundreds of vector types, and enable you to perform comprehensive studies of gene function. We also provide ready-to-use viral particles in either lentivirus, adenovirus, or AAV.

GeneCopoeia's decades of experience in plasmid cloning and viral particle production, combined with our reagents for RT-qPCR and luciferase detection, enabled us to quickly meet the challenge of helping to fight the COVID-19 pandemic. We offer SARS-CoV-2 Spike-pseudotyped lentivirus for multiple variants, which is great for screening for neutralizing antibodies quantitatively in a safe laboratory environment. Plasmid clones expressing SARS-CoV-2 viral proteins and host factors provide you with tools for studying viral life cycle and developing antiviral drugs.  Antigen protein microarrays let you explore the relationships between interferon depletion and autoimmunity in COVID-19 disease severity. We also offer SARS-CoV-2 RT-qPCR-based detection kits that provide superior sensitivity and specificity.

To browse specific products of interest, please follow the tabs below:

 

SARS-CoV-2 and Cancer-related Products and Services

Cancer patients, who are often immunosuppressed, are particularly vulnerable to complications due to COVID-19. GeneCopoeia has you covered for both cancer and COVID-19 research with industry-leading products and services. You can choose from a wide variety of tools for vaccine evaluation, such as Spike-pseudotyped lentiviruses, receptor stable cell lines, and neutralizing antibody screening services, as well as products for cancer gene function studies, including CRISPR-Cas9, shRNA, miRNA, ORF clones, and cancer biomarker mutation cell lines. For more information, please contact inquiry@gmail.com.

To browse specific products of interest, please follow the tabs below: